Skip to main content
Year archive

PERCHERON THERAPEUTICS LIMITED — 2006 filings

All 42 regulatory filings released by PERCHERON THERAPEUTICS LIMITED (PER) in 2006, sourced directly from the official regulator.

42 Filings
2006 Period
2006 filings (42)
Filing Released Lang
ATL1103 to Prgogress Towards Clinical Development 2 pages ?Kb
Regulatory Filings
2006-12-19 English
Becoming a substantial holder 3 pages ?Kb
Regulatory Filings
2006-11-15 English
Appendix 3B 8 pages ?Kb
Capital/Financing Update
2006-11-14 English
Section 708A Notice 1 page ?Kb
Regulatory Filings
2006-11-14 English
Share Placement to Overseas Institutional Investors 1
Regulatory Filings
2006-11-12 English
Market Developments 1 page ?Kb
Regulatory Filings
2006-11-12 English
Appendix 3B 8 pages ?Kb
Share Issue/Capital Change
2006-11-12 English
Section 708A(5)(e) of Corps Act 1 page ?Kb
Capital/Financing Update
2006-11-12 English
Appointment of new Company Secretary 1 page ?Kb
Board/Management Information
2006-11-08 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2006-11-02 English
Commitments Test Entity - First Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2006-10-23 English
Animal Study Results Support Potential of ATL1102 for MS 1
Regulatory Filings
2006-10-10 English
Results of Meeting 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements
2006-10-09 English
Hdr Correction: ATL1102 Phase IIa MS Trial Update 1
Capital/Financing Update
2006-10-08 English
Chairman's Address and Managing Director's Presentation 19 pages ?Kb
AGM Information
2006-10-08 English
ATL1002 Phase IIa Multiple Sclerosis Trial Update 1
Regulatory Filings
2006-10-03 English
Seminar by Dr Frank Bennett at Bio21 Institute 1 pa
Regulatory Filings
2006-10-02 English
Notice of AGM & Annual Report 2006 65 pages ?Kb
Annual Report
2006-09-07 English
Lead Compound ATL1102 - Patent Granted in Japan 1 p
Regulatory Filings
2006-08-28 English
Preliminary Final Report 44 pages ?Kb
Annual Report
2006-08-06 English
Final Director's Interest Notice 2 pages ?Kb
Director's Dealing
2006-08-01 English
Initial Director's Interest Notice 2 pages ?Kb
Director's Dealing
2006-08-01 English
Commitments Test Entity - Fourth Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2006-07-24 English
Retirement and Appointment of Non-Executive Directors 1
Board/Management Information
2006-07-06 English
Market Developments 1 page ?Kb
Regulatory Filings
2006-06-29 English
Audio Broadcast 1 page ?Kb
Regulatory Filings
2006-06-27 English
Commencement of Dosing of Patients in Phase IIa M.S. Trial 1
Regulatory Filings
2006-06-20 English
Company Secretary Appointment 1 page ?Kb
Regulatory Filings
2006-06-19 English
FDA approves the reintroduction of Tysabri 2 pages ?Kb
Regulatory Filings
2006-06-06 English
Trading Halt 1 page ?Kb
Regulatory Filings
2006-06-05 English
Market Developments - 2nd Generation Antisense Drugs 1
Regulatory Filings
2006-04-27 English
Commitments Test Entity - Third Quarter Report 6 pages ?Kb
Interim / Quarterly Report
2006-04-18 English
Appendix 3B 9 pages ?Kb
Capital/Financing Update
2006-04-09 English
Section 708A(5)(e) Notice 1 page ?Kb
Capital/Financing Update
2006-04-09 English
Results of EGM 1 page ?Kb
Declaration of Voting Results & Voting Rights Announcements
2006-04-05 English
Company Update 2 pages ?Kb
Capital/Financing Update
2006-04-03 English
Market Developments 2 pages ?Kb
Regulatory Filings
2006-03-08 English
Notice of Extraordinary General Meeting 15 pages ?Kb
Regulatory Filings
2006-03-02 English
Half Yearly Report & Half Year Accounts 23 pages ?Kb
Regulatory Filings
2006-02-16 English
Trading Halt 1 page ?Kb
Regulatory Filings
2006-02-14 English
Commitments Test Entity - Second Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2006-01-18 English
Approval to restart Phase IIa in MS patients 3 pages ?Kb
Regulatory Filings
2006-01-11 English